Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: Fortuitous association?;Polyradiculonévrite chronique et sarcoïdose: Association fortuite

Revue Neurologique

Volumn 163, Issue HS1, 2007, Pages

  Ducray, F ^a   Costedoat Chalumeau, N ^b   Bouhour, F ^a   Rousset, H ^c   Vial, C ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Intravenous immunoglobulin; Sarcoidosis

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN;

ADULT; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; HUMAN; IMMUNOTHERAPY; MALE; RELAPSE; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 34948814064     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)92165-7     Document Type: Conference Paper

References (20)

1. BAUGHMAN RP, LOWER EE, DU BOIS RM. (2003). Sarcoidosis. Lancet, 361: 1111-1118.
2. BOUCHARD C, LACROIX C, PLANTÉ V, et al. (1999). Clinicopathological findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology, 52: 498-503.
3. BURNS TM, DYCK PJ, AKSAMIT AJ. (2006). The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases. J Neurol Sci, 244: 77-87.
4. CHAPELON C, ZIZA JM, PIETTE JC, et al. (1990). Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine, 69: 261-276.
5. DE MARCO O, RIFFAUD L, PINEL JF, et al. (2003). Sarcoïdose systémique révé lée par une polyradiculonévrite aiguë sensitive ataxiante. Rev Neurol, 159: 1060-1062.
6. FERRIBY D, DE SÈZE J, STOJKOVIC T, et al. (2000). Manifestations cliniques et approche thérapeutique de la neurosarcoïdose : 40 cas. Rev Neurol, 156: 965-975.
7. GAINSBOROUGH N, HALL SM, HUGHES RA, et al. (1991). Sarcoid neuropathy. J Neurol, 238: 177-180.
8. HEANEY D, GEDDES JF, NAGENDREN K, et al. (2004). Sarcoid polyneuropathy responsive to intravenous immunoglobulin. Muscle Nerve, 29: 447-450.
9. HOITSMA E, FABER CG, DRENT M, et al. (2004). Neurosarcoidosis: a clinical dilemma. Lancet Neurol, 3: 397-407.
10. HOITSMA E, MARZINIAK M, FABER CG, et al. (2004). Small fibre neuropathy in sarcoidosis. Lancet, 359: 2085-2086.
11. KOLLER H, KIESEIER BC, JANDER S, et al. (2005). Chronic inflammatory demyelinating polyneuropathy. N Engl J Med, 352: 1343-1356.
12. LEVY Y, UZIEL Y, ZANDMAN G, et al. (2005). Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann N Y Acad Sci, 1051: 779-786.
13. MYGLAND A, MONSTAD P. (2001). Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol, 8: 157-165.
14. NEMNI R, GALASSI G, COHEN M, et al. (1981). Symmetric sarcoid polyneuropathy: analysis of a sural nerve biopsy. Neurology, 31: 1217-1223.
15. OH SJ. (1980). Sarcoid polyneuropathy: a histologically proved case. Ann Neurol, 7: 178-181.
16. OKSANEN V. (1986). Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand, 73: 283-290.
17. SAID G, LACROIX C, PLANTE-BORDENEUVE V, et al. (2002). Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain, 125: 264-275.
18. SCHOTT B, MICHEL D, LEJEUNE E, et al. (1968). Polyradiculonévrites au cours de la maladie de Besnier-Boeck-Schaumann. J Med Lyon, 49: 931-937.
19. SHARMA OP. (1997). Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest, 112: 220-228.
20. SUZUKI C, TOMIYAMA M, BABA M, et al. (2006). Reversible multifocal conduction block in sarcoid neuropathy. J Peripher Nerv Syst, 11: 93-95.